Literature DB >> 6142993

Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).

I R Peake, B L Furlong, A L Bloom.   

Abstract

DNA from a patient with severe factor IX deficiency (haemophilia B) in whom an inhibitor to factor IX had developed was studied with four genomic gene probes specific for the factor IX gene. All gave a negative result, indicating at least a partial gene deletion. Eight female relatives, covering four generations, were also studied. Restriction-enzyme-fragmented DNA was probed in each case and the level of binding assessed by darkening of the autoradiograph. The DNA of this patient's sister and mother had reduced signals, when compared with that of normal female subjects, indicating the presence of the defective gene. However, the other six female subjects (grandmother, great-grandmother, maternal aunt, and three female cousins) had normal signals. Levels of factor IX and factor IX antigen were also normal in these subjects. By direct gene analysis in this family, the point of mutation has been identified (mother) and diagnosis of the sister as a carrier confirmed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142993     DOI: 10.1016/s0140-6736(84)90123-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

Authors:  B G Schach; S Yoshitake; E W Davie
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  An intragenic deletion of the factor IX gene in a family with hemophilia B.

Authors:  S H Chen; S Yoshitake; P F Chance; G L Bray; A R Thompson; C R Scott; K Kurachi
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

3.  Application of three intragenic DNA polymorphisms for carrier detection in haemophilia B.

Authors:  J M Connor; A F Pettigrew; C Shiach; I M Hann; G D Lowe; C D Forbes
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

4.  Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.

Authors:  R J Matthews; D S Anson; I R Peake; A L Bloom
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

5.  Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX.

Authors:  R A McGraw; L M Davis; C M Noyes; R L Lundblad; H R Roberts; J B Graham; D W Stafford
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Polymorphism of normal factor IX detected by mouse monoclonal antibodies.

Authors:  A Wallmark; R Ljung; I M Nilsson; L Holmberg; U Hedner; M Lindvall; H O Sjögren
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  An insertion within the factor IX gene: hemophilia BEl Salvador.

Authors:  S H Chen; C R Scott; J R Edson; K Kurachi
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

8.  Carrier detection through the use of abnormal deletion junction fragments in a case of haemophilia B involving complete deletion of the factor IX gene.

Authors:  R J Matthews; I R Peake; A L Bloom; D S Anson
Journal:  J Med Genet       Date:  1988-11       Impact factor: 6.318

9.  Application of an intragenic genomic probe to genetic counselling for haemophilia B in the west of Scotland.

Authors:  J M Connor; A F Pettigrew; I M Hann; C D Forbes; G D Lowe; N A Affara
Journal:  J Med Genet       Date:  1985-12       Impact factor: 6.318

10.  Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes.

Authors:  M C Poon; D H Chui; M Patterson; D M Starozik; L S Dimnik; D I Hoar
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.